Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.

Nejadmoghaddam MR, Zarnani AH, Ghahremanzadeh R, Ghods R, Mahmoudian J, Yousefi M, Nazari M, Ghahremani MH, Abolhasani M, Anissian A, Mahmoudi M, Dinarvand R

Open source

DOI
10.1038/s41598-025-00193-1
Published
2025 May 7
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-025-00193-1,
  title = {Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.},
  author = {Nejadmoghaddam MR and Zarnani AH and Ghahremanzadeh R and Ghods R and Mahmoudian J and Yousefi M and Nazari M and Ghahremani MH and Abolhasani M and Anissian A and Mahmoudi M and Dinarvand R},
  year = {2025},
  journal = {Scientific reports},
  doi = {10.1038/s41598-025-00193-1},
  url = {https://doi.org/10.1038/s41598-025-00193-1}
}

RIS

TY  - JOUR
TI  - Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.
AU  - Nejadmoghaddam MR
AU  - Zarnani AH
AU  - Ghahremanzadeh R
AU  - Ghods R
AU  - Mahmoudian J
AU  - Yousefi M
AU  - Nazari M
AU  - Ghahremani MH
AU  - Abolhasani M
AU  - Anissian A
AU  - Mahmoudi M
AU  - Dinarvand R
PY  - 2025
JO  - Scientific reports
DO  - 10.1038/s41598-025-00193-1
UR  - https://doi.org/10.1038/s41598-025-00193-1
ER  - 

APA

MR, N., AH, Z., R, G., R, G., J, M., M, Y., M, N., MH, G., M, A., A, A., M, M., & R, D. (2025). Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.. Scientific reports. https://doi.org/10.1038/s41598-025-00193-1

Source records